AAO 2026 – Clinical Trial Updates Part III
Emily H. Jung, MD Duke Eye Center, Durham, NC GLOW2 Study: Phase 3 Study of Tarcocimab for Diabetic Retinopathy Margaret A. Chang, MD (Retinal Consultants Medical Group, Sacramento, CA) Dr.…
Category: Diabetic Retinopathy
Retina Society 2026 – Artificial Intelligence Session
Justin C. Muste, Timothy T. Xu, Erik Massenzio, Collin J. Richards Wills Eye Hospital Retinal Aging Clocks Based on Deep Learning Predictions of Age From Retinal Images are Associated…
Retina Society 2026 – Margherio and Fellowship Award
Margherio Award — Outer Segment Thinning and Polygenic Risk Interact to Predict AMD The Margherio Award at this year’s Retina Society annual meeting (September 25, 2026) was awarded to Dr.…
The 2026 ASRS Awards Ceremony
Ashley Zhou, MD and Charlie Zhang, MD The 2026 ASRS Awards Ceremony celebrated leaders whose innovations in research, surgery, education, and mentorship have shaped the field of retina while highlighting…
ASRS 2026: Late Breaking Abstracts
Saif Hamdan, MD Vanderbilt Eye Institute, Nashville, TN Grace Baldwin, MD Mass Eye and Ear, Boston, MA On the final day of the 2026 ASRS Annual meeting, the late-breaking abstracts…
ASRS 2026: Neovascular AMD and Non-Neovascular AMD Session II
Blake Hauser, MD, PhD and Sandra Hoyek, MD Massachusetts Eye and Ear, Boston, MA Friday morning at ASRS 2026 kicked off with back-to-back age-related macular degeneration (AMD) symposia: Innovations in…
Atlantic Coast Retina Club/Macula 2026: Diabetic Retinopathy and RVO
Collin Richards, MD Wills Eye Hospital, Philadelphia, PA Neil M. Bressler, MD Anti-VEGF monotherapy for diabetic retinopathy and diabetic macular edema is an underappreciated but highly effective approach, particularly in…
AAO Subday 2025: NEW DAY Fluocinolone Implant for DME
Luis Acaba-Berrocal MD Wills Eye Hospital, Philadelphia, PA The Late-Breaking Abstract session at Retina Subspecialty Day highlighted several important clinical trials in diabetic macular edema and diabetic retinopathy. Among them…